|

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

RECRUITINGSponsored by Odense University Hospital
Actively Recruiting
SponsorOdense University Hospital
Started2015-08
Est. completion2024-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05258448

Summary

Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 Years
* Inoperable and histologically/cytologically verified NSCLC.
* Planned treatment with curative intent.
* Capable of completing study procedures ECG and Cardiac MR.
* Able of giving written and informed consent before study procedures are initiated.

Exclusion Criteria:

* Vulnerable patients.
* Patients with operable devices as pacemaker/ICD and cochlear implant or other conditions where MR scan is contraindicated.
* Claustrophobia.

Conditions8

CancerCardiac DiseaseCardiac ToxicityHeart DiseaseLung CancerLung Cancer Stage IILung Cancer Stage IIIRadiation Toxicity

Browse More Trials

Cancer trialsHeart Disease trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.